GH vs MSCI · rev $636.6M vs P/E 37, rev $1.72B
Guardant Health Inc (GH) versus MSCI Inc (MSCI) — a side-by-side from cached financials, not a winner call.
Guardant Health Inc (GH) is a diagnostics & research company listed on US.
MSCI Inc (MSCI) is a financial data & stock exchanges company listed on US.
Latest reported GH revenue for 2026-06-30 was $636.6M. Net income was -$232.2M. GH currently screens at market cap $6.32B.
Latest reported MSCI revenue for 2026-06-30 was $1.72B. Net income was $748.0M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
GH currently screens at market cap $6.32B. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
Not investment advice. Open the GH and MSCI stock pages for the full models.
Not investment advice.